Literature DB >> 17999616

Realizing telemedicine advantages at the national level: cases from the United Arab Emirates.

Nabeel Al-Qirim1.   

Abstract

This research was initiated to explore telemedicine adoption and diffusion in healthcare organizations in the United Arab Emirates (UAE). Research on telemedicine applications in the UAE focused on two main areas. First, it was revealed that the telemedicine application was not extensively employed in the UAE. There are no self-initiated telemedicine networks or specialty telemedicine centers in the UAE. A study was conducted on the perceptions of UAE healthcare professional concerning their attitudes and behavior toward adopting the telemedicine technology in their organizations, using a theoretical construct extended from the technological innovation literature. Second, existing telemedicine activities were initiated in cooperation with the Mayo Clinic. These consist of multimedia telemedicine systems for second opinion tele-consultations. The effectiveness of this approach has also been examined. The research discusses the findings in the light of the overall literature, highlighting further implications and suggesting ways where telemedicine could be applied in the UAE. There is still much growth and opportunity for self-governed specialty telemedicine systems and networks in the UAE.

Entities:  

Mesh:

Year:  2007        PMID: 17999616     DOI: 10.1089/tmj.2006.0087

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  2 in total

1.  User Acceptance Level of and Attitudes towards Telemedicine in the United Arab Emirates: A quantitative study.

Authors:  Shaikha Abdool; Sherief Abdallah; Suhair Akhlaq; Hira Abdul Razzak
Journal:  Sultan Qaboos Univ Med J       Date:  2021-06-21

2.  Factors Determining the Success and Failure of eHealth Interventions: Systematic Review of the Literature.

Authors:  Conceição Granja; Wouter Janssen; Monika Alise Johansen
Journal:  J Med Internet Res       Date:  2018-05-01       Impact factor: 5.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.